摘要: Preventing fractures in elderly people is a priority, especially as it has been predicted that 20 years almost quarter of Europe will be aged over 65. This article describes the factors contributing to fracture, interventions prevent and various treatments.
core.ac.uk
highwire.org参考文章(59)
D Felsenberg, T Schnitzer, R R Recker, S Adami, M McClung, H G Bone, C Roux, D Kiel, A Kaur, R Emkey, M A Levine, G Crepaldi, A J Foldes, S L Greenspan, A C Santora nd, A Pinchera, D E Thompson, J J Orloff, R P Tonino, J Yates, Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group. Aging (Milan, Italy). ,vol. 12, pp. 1- 12 ,(2000)
Youm T, Kummer Fj, Zuckerman Jd, Koval Kj, Do all hip fractures result from a fall The American journal of orthopedics. ,vol. 28, pp. 190- 194 ,(1999)
J.-Y. Reginster, H. W. Minne, O. H. Sorensen, M. Hooper, C. Roux, M. L. Brandi, B. Lund, D. Ethgen, S. Pack, I. Roumagnac, R. Eastell, Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis Osteoporosis International. ,vol. 11, pp. 83- 91 ,(2000) , 10.1007/S001980050010
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
A D Oxman, R B Haynes, M A Thomson, D A Davis, No magic bullets: a systematic review of 102 trials of interventions to improve professional practice Canadian Medical Association Journal. ,vol. 153, pp. 1423- 1431 ,(1995)
T. Schnitzer, , H. G. Bone, G. Crepaldi, S. Adami, M. McClung, D. Kiel, D. Felsenberg, R. R. Recker, R. P. Tonino, C. Roux, A. Pinchera, A. J. Foldes, S. L. Greenspan, M. A. Levine, R. Emkey, A. C. Santora, A. Kaur, D. E. Thompson, J. Yates, J. J. Orloff, Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis Aging Clinical and Experimental Research. ,vol. 12, pp. 1- 12 ,(2000) , 10.1007/BF03339822
Tommy Storm, Gorm Thamsborg, Torben Steiniche, Harry K. Genant, Ole Helmer Sorensen, Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis New England Journal of Medicine. ,vol. 322, pp. 1265- 1271 ,(1990) , 10.1056/NEJM199005033221803
Jane A Cauley, Larry Norton, Marc E Lippman, Stephen Eckert, Kathryn A Krueger, David W Purdie, Jordi Farrerons, Avraham Karasik, Dan Mellstrom, Kong Wah Ng, Jan J Stepan, Trevor J Powles, Monica Morrow, Alberto Costa, Sheryl L Silfen, Erin L Walls, Henry Schmitt, Douglas B Muchmore, V Craig Jordan, None, Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Breast Cancer Research and Treatment. ,vol. 65, pp. 125- 134 ,(2001) , 10.1023/A:1006478317173
J.P. Brown, D.L. Kendler, M.R. McClung, R.D. Emkey, J.D. Adachi, M.A. Bolognese, Z. Li, A. Balske, R. Lindsay, The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. Calcified Tissue International. ,vol. 71, pp. 103- 111 ,(2002) , 10.1007/S00223-002-2011-8
Charles H Chesnut III, Stuart Silverman, Kim Andriano, Harry Genant, Alberto Gimona, Steven Harris, Douglas Kiel, Meryl LeBoff, Michael Maricic, Paul Miller, Caje Moniz, Munro Peacock, Peter Richardson, Nelson Watts, David Baylink, PROOF Study Group, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study The American Journal of Medicine. ,vol. 109, pp. 267- 276 ,(2000) , 10.1016/S0002-9343(00)00490-3